GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery

Name: GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
Published: 2009
License: Public Domain

National Cancer Institute (NCI) · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

pancreatic-ductal-adenocarcinoma

adult solid neoplasm, pancreatic acinar cell carcinoma, pancreatic ductal adenocarcinoma, recurrent pancreatic carcinoma, stage iv pancreatic cancer ajcc v6 and v7, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery

Related documents